TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11191179

Group type: EXPERIMENTAL
Intervention: Flumazenil 0.5 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Flumazenil 2.5 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Flumazenil 5.0 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Flumazenil (all doses)
Number of subjects: 16
Study: 9197295

Group type: EXPERIMENTAL
Intervention: 60% xenon
Number of subjects: 30

Group type: COMPARATOR
Intervention: 60% N2O + 0.5% isoflurane
Number of subjects: 30

Group type: COMPARATOR
Intervention: 60% N2O + 0.70% sevoflurane
Number of subjects: 30
Study: 1307893

Group type: EXPERIMENTAL
Intervention: Bedside measurement of activated clotting time (ACT) by nursing staff with management by protocol.
Number of subjects: 254

Group type: COMPARATOR
Intervention: Independent medical decisions by resident medical staff.
Number of subjects: 254
Study: 3095507

Group type: EXPERIMENTAL
Intervention: Mannitol for ICP elevations greater than 25 mm Hg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Empirical mannitol therapy irrespective of ICP readings
Number of subjects: 80
Study: 29332056

Group type: COMPARATOR
Intervention: Percutaneous ozone injection alone (Control)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Combined ozone injection and percutaneous microdiscectomy (Treatment)
Number of subjects: 47
Study: 27476806

Group type: EXPERIMENTAL
Intervention: Long-acting injectable second-generation antipsychotic
Number of subjects: 305

Group type: COMPARATOR
Intervention: Oral second-generation antipsychotic
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Subsequent relapses
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Long-acting injectable medication administration schedule
Number of subjects: 305
Study: 25473212

Group type: EXPERIMENTAL
Intervention: TheraFill® (porcine collagen filler)
Number of subjects: 61

Group type: COMPARATOR
Intervention: KOKEN® (bovine collagen filler)
Number of subjects: 61
Study: 22324458

Group type: EXPERIMENTAL
Intervention: Standardized assessment and evidence-based treatment for urinary incontinence
Number of subjects: 225
Study: 20399995

Group type: EXPERIMENTAL
Intervention: Test formulation A (valsartan 160 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Test formulation B (valsartan 160 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Reference formulation (valsartan 160 mg)
Number of subjects: 18
Study: 18512043

Group type: EXPERIMENTAL
Intervention: Euglycaemia (blood glucose level at 5 mmol/l)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Hyperglycaemia (blood glucose level at 11 mmol/l)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Euglycaemia
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Hyperglycaemia
Number of subjects: 7
Study: 17310949

Group type: EXPERIMENTAL
Intervention: DNAase treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antibacterial therapy
Number of subjects: 0
Study: 14671698

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced duplex ultrasound (Definity, infused at 2 to 4 mL/min)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard duplex ultrasound
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced duplex ultrasound
Number of subjects: 22
Study: 11007149

Group type: EXPERIMENTAL
Intervention: Behavioral counseling
Number of subjects: 291

Group type: COMPARATOR
Intervention: Standard advice
Number of subjects: 291
Study: 9179187

Group type: EXPERIMENTAL
Intervention: Androgen ablation therapy (AAT)
Number of subjects: 258

Group type: COMPARATOR
Intervention: No androgen ablation therapy (no AAT)
Number of subjects: 258
Study: 1350140

Group type: EXPERIMENTAL
Intervention: Subcutaneous interferon alpha 2a plus cryotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cryotherapy alone
Number of subjects: 0
Study: 2859970

Group type: EXPERIMENTAL
Intervention: Terbutaline, 0.5 mg intravenously
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Prenalterol, 1.0 and 4.0 mg intravenously
Number of subjects: 12
Study: 31821915

Group type: EXPERIMENTAL
Intervention: Four-quadrant osteoplastic decompressive craniotomy (FoQOsD)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Conventional decompressive craniectomy (DC)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Presence of intraventricular hemorrhage and subarachnoid hemorrhage
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Opposite side contusions
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Anisocoria
Number of subjects: 115
Study: 30791502

Group type: EXPERIMENTAL
Intervention: Dietary feedback text messaging intervention
Number of subjects: 143
Study: 28535438

Group type: EXPERIMENTAL
Intervention: Edoxaban 60 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Edoxaban 90 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Edoxaban 60 mg in sodium citrate tubes
Number of subjects: 30

Group type: COMPARATOR
Intervention: Edoxaban 90 mg in sodium citrate tubes
Number of subjects: 30
Study: 25732165

Group type: EXPERIMENTAL
Intervention: Cytarabine 200 mg/m2 continuous IV infusion once per day on days 1 to 7 plus amonafide 600 mg/m2 IV over 4 hours on days 1 to 5 (A + C arm)
Number of subjects: 433

Group type: COMPARATOR
Intervention: Cytarabine 200 mg/m2 continuous IV infusion once per day on days 1 to 7 plus daunorubicin 45 mg/m2 IV over 30 minutes once per day on days 1 to 3 (D + C arm)
Number of subjects: 433
Study: 23800209

Group type: EXPERIMENTAL
Intervention: Preoperatively planned surgery using VSP software
Number of subjects: 5

Group type: COMPARATOR
Intervention: Free-hand surgery without VSP software
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Both interventions (VSP and free-hand)
Number of subjects: 5
Study: 21790765

Group type: EXPERIMENTAL
Intervention: N-butylscopolammonium bromide (NBB) 0.3 mg/kg bwt i.v.
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Xylazine 0.25 mg/kg bwt i.v.
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Combination of NBB (0.3 mg/kg bwt) and xylazine (0.25 mg/kg bwt) i.v.
Number of subjects: 6
Study: 19561254

Group type: EXPERIMENTAL
Intervention: US-guided percutaneous treatment
Number of subjects: 287
Study: 16756418

Group type: EXPERIMENTAL
Intervention: Low-magnitude voucher group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Medication contingency group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard treatment group
Number of subjects: 60
Study: 15472588

Group type: EXPERIMENTAL
Intervention: Stripping of the long saphenous vein
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ligation alone
Number of subjects: 100
Study: 11199739

Group type: EXPERIMENTAL
Intervention: Drying with one paper point
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Drying with four paper points
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Drying with four paper points followed by a gentle burst of warm air
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Drying with four paper points followed by an internal 200 degrees C heat probe
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Glass ionomer sealer
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Zinc oxide-eugenol sealer
Number of subjects: 80
Study: 9255203

Group type: EXPERIMENTAL
Intervention: Cerebral malaria survivors
Number of subjects: 624
Study: 8222516

Group type: EXPERIMENTAL
Intervention: Noradrenaline infusion (0.015 to 0.075 microgram min‐1 kg‐1) during euhydration
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Noradrenaline infusion (0.015 to 0.075 microgram min‐1 kg‐1) during overhydration
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Noradrenaline infusion
Number of subjects: 15
Study: 2939869

Group type: EXPERIMENTAL
Intervention: Doxazosin 16 mg daily
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg daily
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 30944149

Group type: EXPERIMENTAL
Intervention: PDSAFE physiotherapy programme (individually tailored, progressive home-based fall avoidance strategy training with balance and strengthening exercises)
Number of subjects: 474

Group type: COMPARATOR
Intervention: Control group (routine care, DVD about Parkinson's, single advice session)
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: PDSAFE physiotherapy programme
Number of subjects: 474

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 474
Study: 28252452

Group type: EXPERIMENTAL
Intervention: Aripiprazole once-monthly 400 mg (AOM 400)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paliperidone palmitate (PP)
Number of subjects: 0
Study: 26255249

Group type: EXPERIMENTAL
Intervention: Rituximab (RTX) monotherapy
Number of subjects: 30
Study: 24021562

Group type: EXPERIMENTAL
Intervention: Acupuncture with sensory discrimination training
Number of subjects: 25

Group type: COMPARATOR
Intervention: Acupuncture without sensory discrimination training
Number of subjects: 25
Study: 21497708

Group type: EXPERIMENTAL
Intervention: Pomegranate juice (200 mL twice daily for 2 weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (water)
Number of subjects: 16
Study: 19048695

Group type: EXPERIMENTAL
Intervention: ICE (ifosfamide, carboplatinum, etoposide)
Number of subjects: 73

Group type: COMPARATOR
Intervention: IMVP (ifosfamide, methotrexate, etoposide)
Number of subjects: 73
Study: 17133780

Group type: EXPERIMENTAL
Intervention: Nourkrin (active preparation)
Number of subjects: 55
Study: 12504702

Group type: EXPERIMENTAL
Intervention: Multiquadrant cortical‐cleaving hydrodissection (HY)
Number of subjects: 59

Group type: COMPARATOR
Intervention: No hydrodissection (HN)
Number of subjects: 59
Study: 10393602

Group type: COMPARATOR
Intervention: Intermittent Positive Pressure Ventilation (IPPV)
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: High-Frequency Ventilation (HFV)
Number of subjects: 284
Study: 8753981

Group type: EXPERIMENTAL
Intervention: Bare-sclera technique
Number of subjects: 55

Group type: COMPARATOR
Intervention: Free conjunctiva-limbus transplant
Number of subjects: 55
Study: 1677229

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 micrograms/kg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1.0 micrograms/kg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1.5 micrograms/kg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (all doses)
Number of subjects: 20
Study: 6841074

Group type: EXPERIMENTAL
Intervention: Aromatic retinoid (Ro 10‐9359)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Dapsone
Number of subjects: 4
Study: 29866011

Group type: EXPERIMENTAL
Intervention: Triflusal 300 mg twice daily or 600 mg once daily
Number of subjects: 1119

Group type: COMPARATOR
Intervention: Aspirin 100 mg once daily
Number of subjects: 1119

Group type: EXPERIMENTAL
Intervention: Triflusal
Number of subjects: 1119

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 1119
Study: 29424731

Group type: EXPERIMENTAL
Intervention: Cardiac shock wave therapy (CSWT)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 72
Study: 26768165

Group type: EXPERIMENTAL
Intervention: Dacomitinib
Number of subjects: 121

Group type: COMPARATOR
Intervention: Erlotinib
Number of subjects: 121
Study: 25010443

Group type: EXPERIMENTAL
Intervention: Therapeutic anticoagulation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 70
Study: 21691847

Group type: EXPERIMENTAL
Intervention: Older patients (≥ 65 years)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Younger patients (< 65 years)
Number of subjects: 57
Study: 20199764

Group type: EXPERIMENTAL
Intervention: 23-valent pneumococcal polysaccharide vaccine (PPV-23)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 7-valent pneumococcal conjugate vaccine (PCV-7)
Number of subjects: 0
Study: 18043484

Group type: EXPERIMENTAL
Intervention: 800‐mg oral dose of EGCG administered as Polyphenon E under fasting conditions
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 800‐mg oral dose of EGCG administered as Polyphenon E under fed conditions
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: OSS‐3 sampling strategy
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: OSS‐2 sampling strategy
Number of subjects: 10
Study: 16251628

Group type: EXPERIMENTAL
Intervention: Supplementation of breast‐feeding mothers with 60 mg retinol equivalent (RE) vitamin A within 4 wk of delivery
Number of subjects: 1085

Group type: EXPERIMENTAL
Intervention: EPI‐linked supplementation of infants with 7.5 mg RE vitamin A at 6, 10, and 14 wk
Number of subjects: 1085

Group type: EXPERIMENTAL
Intervention: Combined mother and child supplementations
Number of subjects: 1085

Group type: COMPARATOR
Intervention: Placebo for mother and child
Number of subjects: 1085
Study: 12093601

Group type: EXPERIMENTAL
Intervention: Brahmi (Bacopa monnieri)
Number of subjects: 76
Study: 10342896

Group type: EXPERIMENTAL
Intervention: Cigarette smoking (current smokers)
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Dietary fat intake
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Family history of lung cancer
Number of subjects: 507

Group type: COMPARATOR
Intervention: Residential patterns, air quality, occupation
Number of subjects: 507
Study: 7500240

Group type: EXPERIMENTAL
Intervention: Ultrasonic scaler at full power
Number of subjects: 17

Group type: COMPARATOR
Intervention: Ultrasonic scaler at half power
Number of subjects: 17
Study: 1758201

Group type: EXPERIMENTAL
Intervention: terbutaline 0.5 mg inhaled through a cone spacer with positive expiratory pressure (+PEP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: terbutaline 0.5 mg inhaled through a cone spacer without positive expiratory pressure (‐PEP)
Number of subjects: 0
Study: 7093597

Group type: EXPERIMENTAL
Intervention: Oral amitriptyline (75-225 mg/day)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Intramuscular flupenthixol decanoate (10-30 mg every 14 days)
Number of subjects: 68
Study: 31526640

Group type: EXPERIMENTAL
Intervention: New domestic dacron patch
Number of subjects: 48

Group type: COMPARATOR
Intervention: Imported cardiac polyester patch
Number of subjects: 48
Study: 30762726

Group type: EXPERIMENTAL
Intervention: Virtual bronchoscopic navigation combined with endobronchial ultrasound (VBN+EBUS)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Endobronchial ultrasound (EBUS)
Number of subjects: 115
Study: 28838955

Group type: EXPERIMENTAL
Intervention: Bosutinib 200 mg/d
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Pooled bosutinib (200 mg/d and 400 mg/d)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172
Study: 23782554

Group type: EXPERIMENTAL
Intervention: Milk-free soy-maize-sorghum-based RUTF (SMS-RUTF)
Number of subjects: 1927

Group type: COMPARATOR
Intervention: Standard ready-to-use therapeutic food with 25% milk (P-RUTF)
Number of subjects: 1927
Study: 24830824

Group type: EXPERIMENTAL
Intervention: Dexamethasone intravitreal implant 0.7 mg (DEX implant)
Number of subjects: 427

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 427
Study: 22462654

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Sequence of tamoxifen and letrozole
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: HER-2 normal patients subset of Danish cohort
Number of subjects: 257
Study: 19736426

Group type: EXPERIMENTAL
Intervention: Dexamethasone-cyclophosphamide pulse and daily oral cyclophosphamide (DCP+C)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Cyclophosphamide pulse and daily oral prednisolone (CP+P)
Number of subjects: 28
Study: 17307419

Group type: EXPERIMENTAL
Intervention: Intracoronary beta-irradiation (VBT)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Bare metal stents (control group)
Number of subjects: 61
Study: 15310844

Group type: EXPERIMENTAL
Intervention: Vaccination with genetically engineered allergen derivatives
Number of subjects: 124
Study: 10923750

Group type: EXPERIMENTAL
Intervention: Zotepine (300 mg daily, with fallback to 150 mg if necessary)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study: 9365037

Group type: EXPERIMENTAL
Intervention: One-step polymerase chain reaction assay
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Nested polymerase chain reaction assay
Number of subjects: 35

Group type: COMPARATOR
Intervention: Polymerase chain reaction assay
Number of subjects: 35
Study: 1590226

Group type: EXPERIMENTAL
Intervention: Amiodarone 200 mg/day
Number of subjects: 212

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 212
Study: 3897808

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (2 atmospheres absolute for 20 sessions of 90 minutes, over a period of one month)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo gas mixture
Number of subjects: 41
Study: 3371295

Group type: EXPERIMENTAL
Intervention: Vitamin B-complex
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Safflower oil
Number of subjects: 31

Group type: COMPARATOR
Intervention: EFA nutriture (compared with controls)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Vitamin E levels in patients treated with safflower oil
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Other fatty acids levels
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Clinical features and severity
Number of subjects: 31
Study: 30706798

Group type: COMPARATOR
Intervention: Younger adults (18-49 years) during M1 task
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Older adults (>50 years) during M1 task
Number of subjects: 54

Group type: COMPARATOR
Intervention: Younger adults (18-49 years) during V1 task
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Older adults (>50 years) during V1 task
Number of subjects: 54

Group type: COMPARATOR
Intervention: Younger adults (18-49 years) during V2 task
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Older adults (>50 years) during V2 task
Number of subjects: 54
Study: 29023213

Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg every 2 weeks)
Number of subjects: 854

Group type: COMPARATOR
Intervention: Docetaxel (75 mg/m2 every 3 weeks)
Number of subjects: 854
Study: 26166555

Group type: EXPERIMENTAL
Intervention: High-protein hypocaloric diet (Diet HP)
Number of subjects: 331

Group type: COMPARATOR
Intervention: Standard hypocaloric diet (Diet S)
Number of subjects: 331
Study: 23190599

Group type: EXPERIMENTAL
Intervention: Intervention group (n = 135)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Usual care control group (n = 141)
Number of subjects: 276
Study: 21396130

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18479589

Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Chlorthalidone 6.25 mg + Atenolol 25 mg
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Atenolol 25 mg + Amlodipine 2.5 mg
Number of subjects: 282
Study: 16547959

Group type: EXPERIMENTAL
Intervention: Albuterol
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Racemic epinephrine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 100
Study: 12928310

Group type: EXPERIMENTAL
Intervention: Therapeutic adaptive servoventilation for 1 month
Number of subjects: 30

Group type: COMPARATOR
Intervention: Subtherapeutic adaptive servoventilation for 1 month (Control)
Number of subjects: 30
Study: 11009045

Group type: EXPERIMENTAL
Intervention: Mefloquine (500 mg, 250 mg, 250 mg over 12 h) followed by co-artemether (6 x 4 tablets over 60 h)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Co-artemether alone
Number of subjects: 14

Group type: COMPARATOR
Intervention: Mefloquine alone
Number of subjects: 14
Study: 8884415

Group type: EXPERIMENTAL
Intervention: Strength training program (48 sessions, 3 sessions/week)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (sedentary lifestyle)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 30
Study: 1405960

Group type: EXPERIMENTAL
Intervention: Canal preparation with Betadine and alcohol
Number of subjects: 130

Group type: COMPARATOR
Intervention: Nonprepared (control)
Number of subjects: 130
Study: 4057312

Group type: EXPERIMENTAL
Intervention: Haloperidol 5 mg IM
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29409922

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTX‐A) infiltration
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (saline) infiltration
Number of subjects: 50
Study: 27940715

Group type: EXPERIMENTAL
Intervention: Transcutaneous Bilirubinometry (TcB)
Number of subjects: 430

Group type: COMPARATOR
Intervention: Control (visual and clinical assessment for SB)
Number of subjects: 430
Study: 24762109

Group type: EXPERIMENTAL
Intervention: Low-dose ethinyl estradiol (EE2) during childhood (25 ng/kg/d for ages 5-8 years; 50 ng/kg/d for ages >8-12 years)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 22386119

Group type: EXPERIMENTAL
Intervention: Active and emotional coping strategies
Number of subjects: 1324

Group type: EXPERIMENTAL
Intervention: Withdrawal and oppositional coping strategies
Number of subjects: 1324
Study: 19515367

Group type: EXPERIMENTAL
Intervention: Paroxetine administration for 5 weeks
Number of subjects: 35
Study: 19298040

Group type: EXPERIMENTAL
Intervention: Navigated technique
Number of subjects: 84

Group type: COMPARATOR
Intervention: Nonnavigated technique
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 84
Study: 15795812

Group type: COMPARATOR
Intervention: Water (WAT)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Sports drink (CES)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Sports drink with caffeine (CAF)
Number of subjects: 98
Study: 12450644

Group type: EXPERIMENTAL
Intervention: Buspirone combined with anxiety management training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo combined with anxiety management training
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Buspirone combined with non-directive therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo combined with non-directive therapy
Number of subjects: 60